NCT04473417View on ClinicalTrials.gov

Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 4, 2020

Primary Completion Date

August 26, 2020

Study Completion Date

October 12, 2020

Conditions
Healthy
Interventions
DRUG

Forxiga

single dose administration after 10hr fasting

DRUG

DA-2811

single dose administration after 10hr fasting

DRUG

DA-2811

single dose administration after 10hr fasting

DRUG

DA-2811

single dose administration after high fat and calorie fed diet

Trial Locations (1)

Unknown

Bundangseoul national unversity hospital, Sŏngnam

All Listed Sponsors
lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT04473417 - Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects | Biotech Hunter | Biotech Hunter